BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17574971)

  • 1. Cryptic del(13q14.2) and physiological deletions of immunoglobulin genes detected by high-resolution array comparative genomic hybridization in a patient with indolent chronic lymphocytic leukemia.
    Bernheim A; Dessen P; Lazar V; Auger N; Fauvet D; Clausse B; Turhan A
    Cancer Genet Cytogenet; 2007 Jul; 176(1):89-91. PubMed ID: 17574971
    [No Abstract]   [Full Text] [Related]  

  • 2. Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia.
    Stockero KJ; Fink SR; Smoley SA; Paternoster SF; Shanafelt TD; Call TG; Zent CS; Van Dyke DL; Kay NE; Dewald GW
    Cancer Genet Cytogenet; 2006 Apr; 166(2):152-6. PubMed ID: 16631472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 13q14 deletions are not primary events in B-cell chronic lymphocytic leukemia: a study of 100 patients using fluorescence in situ hybridization.
    Avet-Loiseau H; Devilder MC; Garand R; Bouyge I; Rapp MJ; Milpied N; Harousseau JL; Moisan JP; Bataille R
    Clin Cancer Res; 1996 Oct; 2(10):1673-7. PubMed ID: 9816115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic lymphocytic leukaemia Is terminal del(14)(q24) a new marker for prognostic stratification?
    La Starza R; Barba G; Matteucci C; Crescenzi B; Romoli S; Pierini V; Beacci D; Cantaffa R; Martelli MF; Mecucci C
    Leuk Res; 2006 Dec; 30(12):1569-72. PubMed ID: 16650893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution oligonucleotide array-CGH pinpoints genes involved in cryptic losses in chronic lymphocytic leukemia.
    Tyybakinoja A; Vilpo J; Knuutila S
    Cytogenet Genome Res; 2007; 118(1):8-12. PubMed ID: 17901694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect.
    Dickinson JD; Joshi A; Iqbal J; Sanger W; Bierman PJ; Joshi SS
    Int J Mol Med; 2006 May; 17(5):769-78. PubMed ID: 16596259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent homozygous deletions of the D13S25 locus in chromosome region 13q14 defines the location of a gene critical in leukaemogenesis in chronic B-cell lymphocytic leukaemia.
    Chapman RM; Corcoran MM; Gardiner A; Hawthorn LA; Cowell JK; Oscier DG
    Oncogene; 1994 Apr; 9(4):1289-93. PubMed ID: 8134133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Del(13q14.3) length matters: an integrated analysis of genomic, fluorescence in situ hybridization and clinical data in 169 chronic lymphocytic leukaemia patients with 13q deletion alone or a normal karyotype.
    Mian M; Rinaldi A; Mensah AA; Rossi D; Ladetto M; Forconi F; Marasca R; Gattei V; Zucca E; Cavalli F; Gaidano G; Kwee I; Bertoni F
    Hematol Oncol; 2012 Mar; 30(1):46-9. PubMed ID: 21671253
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular cytogenetic characteristics of chronic lymphocytic leukemia].
    Xu W; Li JY; Pan JL; Qiu HR; Shen YF; Xiao B; Chen LJ; Wu YF; Sheng RL; Xue YQ
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):349-52. PubMed ID: 17044998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14.
    Kapanadze B; Makeeva N; Corcoran M; Jareborg N; Hammarsund M; Baranova A; Zabarovsky E; Vorontsova O; Merup M; Gahrton G; Jansson M; Yankovsky N; Einhorn S; Oscier D; Grandér D; Sangfelt O
    Genomics; 2000 Dec; 70(3):327-34. PubMed ID: 11161783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia.
    Durak B; Akay OM; Aslan V; Ozdemir M; Sahin F; Artan S; Gülbas Z
    Cancer Genet Cytogenet; 2009 Jan; 188(2):65-9. PubMed ID: 19100507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined molecular biological and molecular cytogenetic analysis of genomic changes in 146 patients with B-cell chronic lymphocytic leukemia.
    Berkova A; Pavlistova L; Babicka L; Houskova L; Tajtlova J; Balazi P; Cmunt E; Schwarz J; Karban J; Trneny M; Brezinova J; Zemanova Z; Michalova K
    Neoplasma; 2008; 55(5):400-8. PubMed ID: 18665750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 13q deletions in B-cell lymphoproliferative disorders: frequent association with translocation.
    Struski S; Helias C; Gervais C; Audhuy B; Zamfir A; Herbrecht R; Lessard M
    Cancer Genet Cytogenet; 2007 Apr; 174(2):151-60. PubMed ID: 17452258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia.
    Mabuchi H; Fujii H; Calin G; Alder H; Negrini M; Rassenti L; Kipps TJ; Bullrich F; Croce CM
    Cancer Res; 2001 Apr; 61(7):2870-7. PubMed ID: 11306461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
    Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
    Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transcription map of the 13q14 region, frequently deleted in B-cell chronic lymphocytic leukemia patients].
    Tiazhelova TV; Ivanov DV; Makeeva NV; Kapanadze BI; Nikitin EA; Semov AB; Sangfeldt O; Grander D; Vorob'ev AI; Einhorn S; Iankovskiĭ NK; Baranova AV
    Genetika; 2001 Nov; 37(11):1530-7. PubMed ID: 11771308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH.
    Evers C; Beier M; Poelitz A; Hildebrandt B; Servan K; Drechsler M; Germing U; Royer HD; Royer-Pokora B
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1119-28. PubMed ID: 17823930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia.
    Patel A; Kang SH; Lennon PA; Li YF; Rao PN; Abruzzo L; Shaw C; Chinault AC; Cheung SW
    Am J Hematol; 2008 Jul; 83(7):540-6. PubMed ID: 18161787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative genomic hybridization and fluorescence in situ hybridization in chronic lymphocytic leukemia.
    Jarosova M
    Methods Mol Med; 2004; 97():145-57. PubMed ID: 15064491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.